5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'
Gallagher, C. T., Assi, S., Stair, J. L., Fergus, S., Corazza, Ornella, Corkery, John and Schifano, Fabrizio
(2012)
5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'.
Human Psychopharmacology: Clinical and Experimental (2).
pp. 106-112.
ISSN 1099-1077
The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides both an overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs.
Item Type | Article |
---|---|
Date Deposited | 29 May 2025 09:07 |
Last Modified | 29 May 2025 09:07 |